Epigenetx's Debt Round

Epigenetx raised a round of funding on March 06, 2014.

Epigenetx is a drug discovery and development company using a platform technology developed by leading computational medicinal chemists to discover and develop isoform selective histone deacetylase (H…

Articles about Epigenetx's Debt Round: